Imagine if medicines could act precisely where needed, and nowhere else. Envision them encapsulated in a kind of self-driving taxi traveling through the body, equipped with just the right molecular message to trigger healing at the destination. Welcome to the world of nanomedicine, where chemistry, biophysics, and molecular biology come together at one table. And that’s exactly the table the NanoPrecMed Consortium has built.

Supported by the EU’s INTERREG AT-CZ programme, NanoPrecMed unites six research institutions from Austria and the Czech Republic with one shared mission: to bring nanomedicine out of the ivory tower and into real life.

The Future Is Tiny, and Highly Connected

In Brno, the Brno University of Technology contributes its expertise in analysing complex DNA and RNA structures, aided by its own software tools and high-resolution microscopy. Nearby, Mendel University is developing tailor-made nanoparticles that deliver active substances precisely where they are needed. The goal: a new generation of smart, biocompatible drugs that act like well-programmed couriers within the body. The Biology Centre of the Czech Academy of Sciences in České Budějovice contributes its strength in infection biology by testing and developing vaccines, with nanobioparticles enhancing their effectiveness.

In Linz, two partners focus on molecular-level detail: Johannes Kepler University and the University of Applied Sciences Upper Austria use atomic force microscopy (AFM) to examine surfaces at nanoscale, with high-speed AFM and fluorescence microscopy making molecular dynamics visible. In Vienna, the LBI Trauma Center explores extracellular vesicles – tiny bubbles filled with RNA and proteins – as diagnostic and therapeutic tools. As a research institute working closely with the AUVA (Austria’s General Accident Insurance Institution), LBI Trauma is not only a global leader in biomedical research but also stays closely connected to patient care and clinical needs. It serves as the consortium’s coordinator.

“We’re not just aiming for excellent research – we want it to reach people,” says Prof. Andrew Miller from Mendel University. The science is ready for the next step. What’s missing is the infrastructure.

Opening Doors – to Labs and to Minds

That’s where NanoPrecMed comes in. The initiative isn’t just about research; it’s about building regional infrastructure for nanomedicine. Every year, hundreds of young life science talents are trained in Brno, the home of Gregor Mendel – yet many leave due to a lack of attractive career paths, startups, or a critical mass for sustainable innovation. NanoPrecMed wants to change that.

In May, the consortium opened its doors. Public “Open Lab” workshops were held in Vienna, Linz, and Brno, bringing together research, application, and networking. “We want to show what’s already possible and think together about what could be next,” says project leader Conny Schneider. As a biotechnologist, she knows the limits of the lab. As a science communicator, she understands the importance of crossing those limits.

She’s had eye-opening moments herself thanks to NanoPrecMed: “I’ve been a scientist for 15 years, but today was the first time I saw live how DNA strands move,” she shared during a visit to Linz, where high-speed AFM opened up new perspectives. The all-rounder scientist who masters every discipline perfectly only exists on TV. Even within science, people operate in bubbles. And the leap into the wider world is even greater.

That’s why the Open Lab workshops were designed for those outside the research bubble. Topics ranged from extracellular vesicles and atomic force microscopy to bioinformatic analysis of genetic structure and nanoparticle drug research. With talks, live demonstrations, open discussions, and free consultations, the workshops provided not only insight into cutting-edge technologies but also opportunities for new partnerships and projects. Missed the events in May? Keep an eye out: more workshops are planned for 2026. In the meantime, the consortium welcomes inquiries and collaboration via their website: nanoprecisionmedicine.eu.

“We believe in open doors – not just in labs, but in minds,” says Conny Schneider. “Science works best when it’s shared.”